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The encapsidation of vesicular stomatitis virus (VSV) genome RNA, a prerequisite step to the replication process by the
nucleocapsid protein (N) was studied by its ability to package VSV leader RNA in vitro in a RNase-resistant form. The VSV
leader RNA was derived from the SP6 transcription vector while the N protein was made in rabbit reticulocyte lysate. The
in vitro encapsidation was carried out by translating N mRNA in the presence of 32P-labeled presynthesized leader RNA. The
RNA encapsidation property of the N protein was completely abrogated when the C-terminal five amino acids (VEFDK-COOH)
were deleted. Systematic mutational analyses within the C-terminal five amino acid regions reveal that the RNA encapsi-
dation activity was lost in all mutants except K3 A and K3 R, indicating that C-terminal five amino acids, in particular the
lysine residue play critical role in genome RNA encapsidation. To correlate the in vitro encapsidation abilities of these mutant
N proteins with genome RNA replication, we have used a full-length cDNA clone of VSV genome RNA to rescue infectious
virions from cells expressing L, P, and wt or mutant N proteins and measured the recovery of plaque forming units. The
results indicate that the N mutants that are defective in in vitro encapsidation of leader RNA do not support replication,
establishing the requirement of C-terminal five amino acids of the N protein in viral replication. © 1999 Academic Press
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GINTRODUCTION
Vesicular stomatitis virus (VSV), a negative-strand RNA
irus, remains one of the best-studied animal RNA vi-
uses. This is primarily due to the availability of both in
itro (Banerjee and Barik, 1992; Das et al., 1996) as well
s in vivo (Pattnaik et al., 1992; Lawson et al., 1995;
tillman et al., 1995; Whelan et al., 1995) assay systems
or studying viral transcription and replication processes.
t has been well documented that three virus-encoded
roteins are required for transcription and replication of
he genome RNA (Emerson and Yu, 1975; Banerjee, 1987;
anerjee and Barik, 1992); these include the nucleocap-
id protein N (49 kDa), which enwraps the genome RNA
n an ordered helical structure that serves as the tem-
late for transcription and replication; the phosphopro-
ein P (30 kDa), a subunit of RNA polymerase that func-
ions as a transcription factor; and the RNA-dependent
NA polymerase L (240 kDa). In infected cells, the nu-
leocapsid core that consists of N-RNA complex, the
esident P protein, and the L protein initiate transcription
o generate subgenomic mRNAs, which are translated to
roduce viral proteins required for replication of the
1 Present address: Ross Division, Abbott Laboratories, Columbus,
H.
2 Present address: University of Michigan, Ann Arbor, MI.
3 Present address: Department of Biochemistry, University of Cal-
utta, Calcutta, India.
R4 To whom reprint requests should be addressed.
219enome RNA. During the replicative phase, first a full-
ength complement (antigenome or positive sense) of
enomic RNA is synthesized in the form of a nucleocap-
id, which in turn acts as the template for synthesis of
rogeny negative sense genome-containing nucleocap-
id. Although it is generally believed that the same poly-
erase performs both transcription and replication pro-
esses, our recent findings, however, strongly suggest
hat the transcriptase and replicase are composed of two
istinct complexes containing L-P2–3 (where P is either
imer or trimer) and L-(N-P), respectively (Das et al.,
997). During replication of the genome RNA, a soluble
orm of the N protein is required (Wertz et al., 1987). This
orm of the N protein has been proposed to interact with
ascently transcribed RNA chains from the RNP complex
nd encapsidate the newly synthesized genome RNA in
tightly assembled structure. This results in the forma-
ion of a N-RNA complex containing full-length plus- or
inus-strand genome RNA. The RNA within the newly
ormed N-RNA complex is totally resistant to RNase
igestion. Thus the interaction and subsequent encapsi-
ation of the plus- and the minus-strand genome RNAs
ith the N protein is the fundamental step in the repli-
ative cycle of the virus. It has been suggested that this
nteraction of the N protein with the nascent RNAs oc-
urs within the leader sequence during its synthesis
rom nucleocapsids containing either the positive- or the
egative-strand genome RNA (Blumberg et al., 1983;
iorgi et al., 1983). Thus the positive or negative leader
NAs presumably encode the recognition signal for en-
0042-6822/99 $30.00
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220 DAS ET AL.apsidation by the N protein. Direct evidence that the N
rotein indeed interacts in vivo with the leader RNA
ame from the observation that N protein leader RNA
omplexes are produced in infected cells that are RNase
esistant. Encapsidation by N protein appears to initiate
ithin the first 14 nucleotides of nascent leader RNA,
hich contains A residues repeated at every third base
Giorgi et al., 1983; Nichol and Holland, 1987).
In addition to the N protein, specific roles played by
he phosphoprotein P in the replication process have
lso been documented (Peluso and Moyer, 1988; Howard
nd Wertz, 1989; La Ferla and Peluso, 1989). The in vitro
tudies suggest that the N protein alone can initiate
eplication, but the presence of P protein greatly stimu-
ated the replication reaction. Moreover it was demon-
trated both in vitro and in vivo that N and P proteins form
pecific complexes (Masters and Banerjee, 1988a;
oward and Wertz, 1989; La Ferla and Peluso, 1989;
akacs et al., 1993; Takacs and Banerjee, 1995). How-
ver, the mechanistic role of these N–P complexes in the
ncapsidation process remains an enigma. It has been
roposed that the P protein not only interacts with the N
rotein to keep the latter protein in a replication-compe-
ent state but may also impart specificity to the N protein
o encapsidate the VSV genomic RNAs (Masters and
anerjee, 1988b; Peluso and Moyer, 1988; Howard and
ertz, 1989; Das and Banerjee, 1992). The C-terminal
nd of both N and P proteins appears to be involved in
his interaction process (Takacs et al., 1993; Takacs and
anerjee, 1995). Using the two-hybrid system, we have
emonstrated that the C-terminal 10 amino acids of the P
rotein and C-terminal 5 amino acids of the N protein are
ritical for such N–P interaction (Takacs et al., 1993;
akacs and Banerjee, 1995).
The regulatory roles of cis-acting elements in the ge-
ome RNA during viral replication process have been
xtensively studied using recently developed reverse
enetic system (Wertz et al., 1994; Stillman et al., 1995; Li
nd Pattnaik, 1997). This system has been used success-
ully for VSV to produce genomic or DI RNAs that would
ranscribe or replicate, respectively, in cells in the pres-
nce of cDNA-encoded viral proteins (Pattnaik et al.,
992; Lawson et al., 1995; Stillman et al., 1995; Whelen et
l., 1995). We have recently shown using VSV minirepli-
on, that the P mutant that is defective in forming com-
lex with N is incapable of supporting replication in vivo
Das et al., 1997). These findings supported the notion
hat while transcriptase is composed of L-P2–3 (where P2–3
s a dimer or trimer) the replicase appears to be a
ripartite complex consisting of L-[N–P], which initiates
he replication reaction.
So far, no specific domain(s) within the N protein has
een identified for its genome RNA encapsidation activ-
ty. To map the encapsidation signal within the N protein,
e have developed both in vitro and in vivo assay sys-ems directed toward the encapsidation of VSV genome wNA by the N protein. A series of deletion and substitu-
ion mutants of NNJ protein has been generated and
nalyzed for its ability to support encapsidation of VSVNJ
eader RNA in vitro and replication of genome RNA in
ivo using cDNA clone of VSV using a reverse genetic
ystem. The results presented in this communication
ndicate that C-terminal five amino acids of the N protein,
n particular the penultimate Lysine residue, plays an
mportant role in the encapsidation/or replication of VSV
enome RNA.
RESULTS
he role of the C-terminal end of the N protein in the
ncapsidation of leader RNA in vitro
We have previously shown (Das and Banerjee, 1992,
993) that in vitro as well as bacterially made VSV N
rotein specifically encapsidated leader RNA over non-
eader RNA, rendering the former resistant to RNaseA
igestion. To put our experimental approach in proper
erspective, we repeated the in vitro experiments involv-
ng the encapsidation of leader RNA by heterologous N
rotein. 32P-labeled VSVNJ leader RNA was synthesized
y SP6 polymerase from a pUC 19 vector containing SP6
romoter fused with an insert composed of 47 nucleo-
ides leader sequence (59 sequence of the antigenomic
NA) up to AUG of the N gene (a total 70 nt). As shown
n Fig. 1 by RNaseA protection experiments, the 32P-
abeled VSVNJ leader RNA was encapsidated in vitro by
he N protein of either NJ or IND serotype; the encapsi-
ation appeared to be more efficient by the N protein of
he same serotype (5–6% of input leader RNA) than the
eterologous N (1–2%). Similar observations were also
eported by other laboratories (Smallwood et al., 1994)
FIG. 1. In vitro encapsidation of (1)-leader RNA of VSVNJ by homol-
gous and heterologous N proteins. Increasing amounts of N mRNA of
ither serotype were translated in 30 ml rabbit reticulocyte lysate in the
resence of 0.1 mg 32P-labeled leader RNA (;100,000 cpm). After
ranslation, the samples were treated with RNaseA at a final concen-
ration of 25 mg/ml at 37°C for 30 min. Protected leader RNA was
nalyzed on a 10% polyacrylamide gel containing 8 M urea. Migration
osition of 70-nt-long leader RNA is shown by arrows.here the N protein of either serotype was shown to
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221N PROTEIN C-TERMINAL 5 aa NEEDED IN VIRAL REPLICATIONncapsidate heterologous leader RNAs. Thus taken to-
ether we can conclude that the encapsidation or RNA
inding domain(s) within the N protein of either serotype
re similar and recognize a similar cognate sequence in
he leader RNA of either serotype (Das and Banerjee,
992, 1993). To locate the putative domain(s) responsible
or the encapsidation of the genome RNA within the N
rotein, we initially made a series of deletion mutants of
NJ in both N and C termini with the help of polymerase
hain reaction. For introducing specific mutations at the
-terminal end of the N protein, we amplified a 300-
ucleotide-long DNA fragment of the NNJ gene containing
arious mutations and replaced the PCR-amplified frag-
ents into the wild-type N gene using unique XhoI and
indIII sites of pN109 (Masters and Banerjee, 1988a). To
btain deletion mutations at the N-terminal end, we am-
lified the entire N gene using upstream primers that
ontained a unique EcoRI site followed by respective
eletion mutations and the complementary sequences to
he 59 end of the N gene. The downstream primer con-
ained the complementary sequence to the 39 end of the
gene followed by a HindIII site. The PCR-amplified
roducts were then introduced into pGEM-4 vector at the
coRI and HindIII sites. By these procedures, we created
eletion mutants of the N gene corresponding to 5, 10, or
5 amino acid deletions from the C-terminal end and 5 or
0 amino acid deletions from the N-terminal end (Fig.
A).
The encapsidation activity of the NNJ mutants was
easured with respect of their abilities to encapsidate
SVNJ leader RNA in vitro, in a RNase-resistant form.
esults of the RNaseA protection experiments by N mu-
ants are shown in Fig. 2B. It can be seen that deletion of
s few as five amino acids from the C-terminal end of the
protein totally abrogated the encapsidation of leader
NA by the N protein. In contrast, truncation of 10 amino
cids from the N-terminal end had very little effect on its
NA encapsidation activity. These results suggest that
he encapsidation domain of the N protein probably re-
ides within the C-terminal five amino acids. To confirm
hat all mutant N mRNAs used in the above experiment
ere efficiently translated in the cell-free system, the
35S-labeled N proteins were analyzed by 10% SDS–PAGE.
s shown in Fig. 2C, each mutant N protein was synthe-
ized in comparable amount during the encapsidation
eaction.
We have previously shown that the wt N protein syn-
hesized in vitro enters into the nondenaturing gel when
he nascent protein binds to the endogenous RNA
resent in the rabbit reticulocyte lysate (Masters and
anerjee, 1988b). To test how the above deletion mutants
f the N protein migrate in such gel system, we per-
ormed in vitro translation of the mutant mRNAs in rabbit
eticulocyte lysate and analyzed the products in a 7.5%
ondenaturing polyacrylamide gel. Unlike wild-type or
-terminal mutants, none of the C-terminal truncated N aroteins entered into the 7.5% nondenaturing gel, con-
irming that the C-terminal deletion mutants lacked RNA
inding property (data not shown).
It is important to note that there is a high degree of
mino acid sequence similarity (.80%) between the N
roteins of both NJ and IND serotypes of VSV (Banerjee
t al., 1984). Moreover, if one aligns the C-terminal 10
mino acid sequences of NNJ and NIND, the sequences
re virtually identical to only one nonidentical change
S3 V) (Fig. 3A). Because the deletion of C-terminal five
mino acids completely abolished the encapsidation
roperty of the N protein, we were interested in further
nvestigating the role of individual amino acid within this
egion in the encapsidation of the leader RNA in vitro. We
ook two approaches for mutational analysis of this re-
ion: (1) we removed one amino acid at a time from the
-terminal end and (2) we introduced nonconserved
mino acids in the region by site-directed mutagenesis.
battery of N mutants were constructed, and their en-
apsidation activities were examined as described
FIG. 2. Ability of truncated NNJ proteins to encapsidate VSV leader
NA. (A) Schematic diagram of N protein showing progressive deletion
utants from both termini. The deleted N genes were cloned into
GEM4 vector under SP6 polymerase. CD5, CD10, CD15 indicate de-
etion of 5, 10, and 15 amino acids, respectively, from C-terminal end,
hereas ND5, ND10 indicate 5 and 10 amino acids, respectively, from
-terminal end. (B) Similar RNaseA protection assay as shown in Fig.
was performed by incubating 0.5 mg of each N mRNA with 0.1 mg
2P-labeled leader RNA (;100,000 cpm). Migration position of leader
NA (70 nt) is shown by the arrow. (C) Flurogram of 35S-labeled protein
rofile of mutant N proteins.bove and shown in Fig. 3B. Surprisingly, deletion of the
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222 DAS ET AL.erminal Lys residue totally abrogated the encapsidation
roperty of the N protein. All other mutations altering the
residue or changing VEFDK sequence abolished the
ncapsidation property except for two: K3 R and K3 A.
he replacement of K either by R or A, perhaps, restored
he structural integrity of the N protein necessary for its
ncapsidation activity. The above results suggest that
-terminal five amino acids of the N protein are directly
nvolved in the encapsidation of VSV genome RNA and
onsequently in the replication process.
escue of VSV from cells expressing mutant
proteins
Because the encapsidation by N protein of the viral
enome RNA is a prerequisite step to the replication
rocess, it would be interesting to examine whether the
utant N proteins that are defective in in vitro encapsi-
ation of the leader RNA are also defective in replication
f genome RNA in vivo. So far, all the N mutants used in
ur in vitro studies were made in the N protein of NJ
erotype. Because of the unavailability of a full-length L
ene of VSVNJ, the in vivo reverse genetic system has not
et been developed for New Jersey serotype. On the
ther hand, the recovery of infectious virus from a full-
ength cDNA clone of VSVIND genome RNA has been well
stablished that renders the biology of VSV Indiana se-
otype fully accessible to genetic manipulation (Lawson
t al., 1995; Whelan et al., 1995). To use VSVIND reverse
enetic system for testing the abilities of NNJ mutant
roteins to support genome RNA replication in vivo, it
FIG. 3. Effect of mutation within the C-terminal five amino acids of NNJ
rotein on its encapsidation ability. (A) Alignment of C-terminal amino
cid residues of the N proteins of both NJ and IND serotypes. (B)
NaseA protection analysis of leader RNA was carried out by trans-
ating mutant N mRNAs in rabbit reticulocyte lysate containing 32P-
abeled leader RNA as described in Fig. 2.as necessary first to establish whether the wild-type iNJ could support encapsidation/replication of VSVIND
rom cDNA in the presence of LIND and PIND proteins. On
he basis of the fact that the N proteins of both NJ and
ND serotypes are highly similar (.80%) in amino acid
equence (Banerjee et al., 1984) coupled with the earlier
indings that the N protein of either serotype can encap-
idate heterologous leader RNA (Das and Banerjee,
992, 1993; Smallwood et al., 1994), it is conceivable that
NJ would support rescue of infectious VSVIND in the
resence of LIND and PIND. In this regard, it is important to
ention that VSVIND DI replication has been observed in
ells coinfected with the VSVIND DI particle and wild-type
SVNJ, indicating that the N protein of NJ serotype is able
o encapsidate heterologous (IND serotype) genome
NA in vivo. Therefore we tested the ability of NNJ to
escue VSVIND from an infectious cDNA clone as de-
cribed earlier (Lawson et al., 1995). BHK-21 cells in-
ected with vTF7–3 were transfected with plasmids en-
oding LIND, PIND, full-length cDNA clone of VSVIND anti-
enomic RNA [pFLIND(1)], and either wild-type NNJ or
IND. After 48 h posttransfection, the plates were sub-
ected to repeated freeze–thaw treatment, and the lysate
as passed through 0.2-mm membrane for removing
accinia virus. The recombinant VSV was recovered and
dded to fresh BHK cells for amplification. After 16–24 h
.i. in the presence of araC, the CPE was visualized by
taining with crystal violet. As shown in Fig. 4A, two
lates that contained the N support plasmids of either
erotype showed severe cytopathic effect after 16 h p.i.
y 24 h, no attached cells were observed in these two
lates, whereas virtually all cells remained intact in con-
rol plates that did not have N support plasmid. We also
erformed plaque assay to determine the titer of the
ecombinant VSV released into the medium after 24 h p.i.
he results of the plaque assay shown in Fig. 4B indicate
hat the amount of recombinant virus rescued by NNJ
rotein was comparable with that by NIND. Thus it can be
oncluded that NNJ is indeed able to encapsidate the
enome RNA of VSVIND in vivo and can rescue infectious
irus from cDNA clone in the presence of LIND and PIND.
Next we tested the abilities of NNJ mutants to support
ncapsidation or replication of VSV genome RNA in vivo.
he rescue of infectious VSVIND was carried out as de-
cribed above from BHK cells expressing LIND, PIND, and
he wt or mutant NNJ proteins. The CPE was visualized by
rystal violet staining, and the virus recovery from the
edium after amplification was measured by plaque
ssay. The results shown in Fig. 5 indicate that the N
utants that were incapable of encapsidating leader
NA in vitro did not rescue infectious virus. It can be
een that no CPE or virus recovery was observed by the
utants CDK and VEFDK3 A5. On the other hand, the N
utants K 3 A or ND5 that showed encapsidation ac-
ivity in vitro also supported virus recovery (Fig. 5B). From
hese results we conclude that the N mutants, defective
n in vitro encapsidation of leader RNA, are unable to
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223N PROTEIN C-TERMINAL 5 aa NEEDED IN VIRAL REPLICATIONupport VSV replication, and more importantly a single
ys residue plays a critical role in this process.
To confirm that all N mutants used in the above ex-
eriment were expressed equally, we analyzed the ex-
ression of N proteins in transfected cells by Western
lotting. Under the transfection conditions, comparable
mounts of the mutant N proteins were synthesized in
he transfected cells (data not shown).
DISCUSSION
The N protein of VSV is a vital protein that maintains
he structural integrity of the genome RNA for transcrip-
ion and replication by the RNA polymerase complex.
he genome RNA is assembled with the N protein in
uch a way that the N-protein-bound genome RNA tem-
late becomes resistant to RNase action, indicating a
trong association between the N protein and the ge-
ome RNA. This assembly or the encapsidation of the
FIG. 4. Rescue of VSVIND from cDNA clone by NNJ. (A) BHK cells in
0-mm plates were infected with vTF7–3 at an m.o.i. of 10 and subse-
uently transfected with 3 mg of pNIND or pNNJ, 1 mg of pL, 2 mg of pP,
nd 5 mg of pFL(1) plasmids. After 48 h posttransfection, the virion
articles in the medium were recovered and amplified by infecting
resh BHK cells for 16–24 h. The cytopathic effect (CPE) was visualized
y crystal violet staining. (B) After amplification, the recovery of plaque
orming units (PFU) in the medium was determined by plaque assay.
iD, not determined.enome RNA with the N protein is a fundamental step of
he replication process. The N protein appears to interact
ith the growing RNA chains during replication and
ncapsidates both full-length plus- and minus-strand ge-
ome RNA from 59 to 39 direction. Absence of unas-
embled full-length plus- or minus-strand VSV RNA in the
nfected cells suggests that growing RNA chains are the
arget of N protein interaction. In this study, we have
ttempted to identify a domain(s) responsible for the
ncapsidation activity of the N protein. Besides its RNA
inding activity, the N protein has also been shown to
osses P-binding activity. The presence of N–P complex
n VSV-infected cells as well as its role in viral replication
as been well established (Peluso and Moyer, 1988;
oward and Wertz, 1989). It is believed that the formation
f N–P complex is essential in keeping the N protein in
replication-competent form, which in turn is directly
FIG. 5. Abilities of mutant NNJ proteins to support replication. In vivo
eplication was carried out as described in Fig. 4. (A) CPE by different
mutants. (B) Recovery of PFU after amplification. ND indicates not
etermined.nvolved in the genome RNA encapsidation process.
H
r
r
o
s
t
o
i
a
e
d
d
p
c
N
n
e
i
n
u
t
f
e
r
N
w
s
p
d
t
t
t
r
t
V
s
q
c
l
d
p
(
b
h
(
t
s
t
t
p
e
t
C
r
d
r
d
t
d
t
t
t
t
N
n
d
n
t
s
1
s
a
N
n
c
m
t
i
t
h
s
a
c
i
V
d
r
w
s
e
c
1
P
c
g
w
P
r
r
e
N
i
q
m
s
r
v
v
o
224 DAS ET AL.owever, the mechanism by which the N–P complex
ecognizes the nascent RNA chains for encapsidation
emains unclear. Clearly the structure–function analysis
f the N protein would facilitate understanding the bio-
ynthetic pathways leading to the encapsidation/replica-
ion of the virus.
The interesting finding reported here is the critical role
f C-terminal penultimate lysine residue of the N protein
n the encapsidation process. Deletion of this single
mino acid residue resulted in total abrogation of the
ncapsidation activity (Fig. 3). The lack of RNA encapsi-
ation activity of CDK mutant N protein appears not to be
ue to degradation at the C-terminal end by a protease
resent in the rabbit reticulocyte lysate (or within the
ell), because altering K to D or I similarly abrogated the
function. On the other hand, replacing K with R or A did
ot change its activity. Interestingly, addition of a few
xtra lysine residues to the penultimate lysine also abol-
shed the encapsidation function of the N protein (data
ot shown). These results clearly indicate that the pen-
ltimate lysine residue plays a vital role in determining
he secondary/tertiary structure of the N protein, which
acilitates genome RNA replication. Similar in vitro RNA
ncapsidation by rabies virus N protein also has been
eported (Yang et al., 1998). In this study, the recombinant
protein binds preferentially to rabies virus leader RNA
ith 5- to 10-fold more efficiently than the nonleader RNA
imilar to the observation we made previously for VSV N
rotein (Das and Banerjee, 1992). Moreover studies with
eletion mutants indicate that intact rabies N is required
o encapsidate its cognate leader RNA because trunca-
ion of a minimum 45 amino acids from either the N or C
erminus totally abolished the ability of N to encapsidate
abies leader RNA (Yang et al., 1998). Although the mu-
ational analysis on rabies N was not as extensive as the
SV N protein the basic findings are to some extent
imilar to our results with respect to the structural re-
uirement of the N protein in RNA encapsidation. Re-
ently, using UV-LASER cross-linking of 32P-labeled
eader RNA to rabies virus N protein followed by trypsin
igestion, Kouznetzoff et al. (1998) have shown that a
eptide sequence NH2 S-P-Y-S-S-N within a 55-aa stretch
position 298–352) as being the primary leader RNA
inding site. Interestingly, this amino acid sequence is
ighly conserved among the lyssa and vesiculoviruses
Kouznetzoff et al., 1998). It is presently unclear whether
his RNA binding motif plays a role in maintaining the
tructural integrity of the N-RNA complex or is involved in
he RNA encapsidation process during replication. Mu-
ational analyses of this motif in VSV or rabies virus N
rotein would reveal interesting results with respect to
ncapsidation or structural requirement of the motif. In
his context, it is noteworthy that the hypervariable
-terminal tail of Sendai virus NP protein was found to be
equired for template function but not for RNA encapsi-
ation (Curran et al., 1993). This apparently different tesult from the VSV or rabies systems may indicate the
ifference in the evolutionary strategies developed be-
ween the two families of virus with regard to encapsi-
ation and genome RNA replication.
Because the encapsidation is a prerequisite step to
he replication process, we were interested in correlating
he in vitro encapsidation abilities of the mutant N pro-
eins with the genome RNA replication in vivo. Because
he mutants we used in the in vitro studies were made in
protein of NJ serotype, the replication of VSVIND ge-
ome RNA was carried out in the presence of NNJ to first
etermine whether NNJ could encapsidate VSVIND ge-
ome RNA in vivo. This approach was based on the fact
hat the N proteins of both serotypes are highly con-
erved in terms of amino acid sequence (Banerjee et al.,
984) and on our findings that the N protein of either
erotype can encapsidate heterologous leader RNA (Das
nd Banerjee, 1992, 1993). It was quite apparent that the
protein of NJ serotype could encapsidate VSVIND ge-
ome RNA and rescue virion particles from its cDNA
lone in the presence of LIND and PIND (Fig. 4). It is worth
entioning that the ability of heterologous viral proteins
o support in vivo replication of the RNA of defective
nterfering (DI) particles of two serotypes of VSV was
ested previously (Moyer, 1989). In all combinations of
eterologous coinfections in vivo, DI replication was ob-
erved only in the coinfection with the VSVIND DI particle
nd wild-type VSVNJ, supporting our contention that NNJ is
able of encapsidating VSVIND genome RNA in vivo. Thus
t seems that the antigenomic or plus-sense RNA of
SVIND synthesized by T7 polymerase is first encapsi-
ated by NNJ protein, and the chimeric template is then
eplicated to produce genomic or minus-sense RNA en-
rapped with NNJ. Clearly the L and P proteins of Indiana
erotype were able to replicate the antigenomic RNA
nwrapped with NNJ in vivo. Because it is known that PIND
an form complex with NNJ in vivo (Takacs and Banerjee,
995), it is conceivable that a tripartite complex, LIND-(NNJ-
IND), the presumptive replicase (Das et al., 1997) may
arry out the replication of NNJ-enwrapped VSVIND anti-
enomic RNA. The resultant VSVIND genome RNA en-
rapped with NNJ is subsequently transcribed by LIND and
IND to produce Indiana serotype specific mRNAs and the
eplication of VSVIND genome RNA ensues. Therefore the
ate-limiting step in our in vivo assay system is the
ncapsidation of T7 derived VSVIND antigenomic RNA by
NJ protein. Any defect in this crucial step would certainly
nhibit the formation of template (N-RNA complex) re-
uired for transcription and replication. Thus the NNJ
utants that are defective in encapsidation function
hould not support replication in vivo, and indeed our
esults shown in Fig. 5 support this contention. The
irus-recovery data (Fig. 5) corroborated exactly the in
itro results (Fig. 3), confirming again the important role
f the C-terminal five amino acids especially the penul-imate Lys residue in VSV genome RNA encapsidation/
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225N PROTEIN C-TERMINAL 5 aa NEEDED IN VIRAL REPLICATIONeplication. In rare cases, we have noticed a low level
ecovery of recombinant virion particles (;103 pfu/ml) in
he absence of a N support plasmid under the assay
ondition used. It may be due to low-level expression of
protein directly from the T7-derived antigenomic RNA.
owever, in the presence of NNJ support plasmid, the
irus recovery is greatly enhanced (;107 pfu/ml after
mplification), and this observation is fairly consistent in
ur repeated experiments. To avoid any confusion re-
arding the background level of virus recovery without N,
e performed plaque assay starting from a minimum
ilution of 1024 (Figs. 4 and 5) so that we could eliminate
he background level if any in that particular set of ex-
eriment.
We have demonstrated previously that the C-terminal
egion of the N protein is also involved in its interaction
ith the P protein (Takacs et al., 1993; Takacs and Ban-
rjee, 1995). No N–P complexes were formed when
-terminal five amino acid residues were deleted from
he N protein (Takacs et al., 1993; Takacs and Banerjee,
995). Interestingly, the N mutants such as CDK and
K3 AA, which failed to encapsidate the genome RNA,
ormed complexes with the P protein as wild-type N
Takacs et al., 1993). On the other hand, altering VEF to
ll alanine residues abrogated both RNA encapsida-
ion and P-binding activities (Takacs et al., 1993). Thus
t seems that the DK residues are crucial for RNA en-
apsidation, whereas VEF are needed for P interaction.
he involvement of same C-terminal five amino acid
egions in both RNA encapsidation and P-binding prop-
rties may have some biological significance. It is pos-
ible that in the infected cells, the P protein interacts
ith the C-terminal domain of the N protein to prevent
he latter from binding to cellular or presynthesized
iral specific RNAs as observed earlier (Masters and
anerjee, 1988b; Das and Banerjee, 1992; Yang et al.,
998). Additionally, such interaction possibly maintains
he N–P complex in a replication competent structure
o that it can now recognize nascent 59 ends of the
NA chains for encapsidation or replication. Deletion of
-terminal five amino acid residues of N results in the
omplete loss of RNA encapsidation as well as P inter-
cting activity, possibly due to disruption of its secondary
r tertiary structure. It is possible that the actual RNA
inding domain is located somewhere within the N pro-
ein, such as the highly conserved domain found in the
iddle of the N protein of four vesiculoviruses (Crysler et
l., 1990) or the pentapeptide sequence described above
Kouznetzoff et al., 1998). The accessibility of this domain
o RNA may be dependent on the C-terminal five amino
cids. Mutational analyses in this domain would help
stablish its real function if any. Alternatively, the syn-
hetic oligopeptides corresponding to this middle domain
r the C-terminal end would be useful to study their effect
n N–P interaction as well as encapsidation/or replica-ion of viral genome RNA. This approach may help to Uelineate whether P binding and RNA binding domains
re functionally separable. Using a similar approach,
amashita and Kawai (1990) have demonstrated the vital
ole of the conserved C-terminal 21 amino acids of VSV
protein in viral transcription process. However, the
echanism of inhibition by the oligopeptide correspond-
ng to the C-terminal 21 amino acid regions remains
nknown. Further studies along this line would certainly
elp us gain insight into the structure and function of the
protein in relation to VSV replication.
MATERIALS AND METHODS
ells and viruses
Baby hamster (Syrian) kidney cells, BHK-21 (ATCC;
CL 10) were maintained in DMEM (Gibco, Inc.) media
upplemented with 7% fetal bovine serum (FBS, Gibco).
he Indiana serotype of VSV was purified as described
reviously (Barik and Banerjee, 1991). Recombinant vac-
inia virus (vTF7–3) carrying the bacteriophage T7 RNA
olymerase gene (Fuerst et al., 1987) was propagated as
escribed by Li and Pattnaik (1997).
lasmid constructs
Transcription vectors pN109 (Masters and Banerjee,
988a), pGEM-NIND (Das and Banerjee, 1992), and pGEM-
1) leader (Das and Banerjee, 1992), which link full-
ength copies of the coding regions of the NNJ, NIND, and
1)-leader genes of VSVNJ, respectively, to the RNA poly-
erase promoter of bacteriophage SP6 were used in this
tudies. To make the mutations at C-terminal end of the
NJ protein, we amplified a 300-nucleotide DNA fragment
f the NNJ gene containing various mutations and re-
laced these PCR-amplified fragments into wt NNJ gene
sing unique XhoI and HindIII sites of pN109. In contrast,
o make the mutations at the N-terminal end, we ampli-
ied the entire NNJ gene. In this case, the upstream primer
ontained an unique EcoRI site followed by respective
utations and the complementary sequences to the 59
nd of the NNJ gene, whereas the downstream primer
ontained the complementary sequence to the 39 end of
he NNJ gene followed by a HindIII site. The PCR-ampli-
ied products were then introduced into pGEM-4 vector
t the EcoRI and HindIII sites. PCR conditions were 94°C
or 2 min, 50°C for 2 min, and 72°C for 2 min with a 7-min
xtension at 72°C after 25 cycles. Mutant NNJ sequences
ere identified by sequencing the amplified products,
nsuring that additional mutations were not introduced
y PCR.
pVSVFL(1), pBS-N, pBS-P, and pBS-L containing full-
ength copies of 11 161-nt-long antigenomic VSV RNA
equence, coding regions of N, P, and L, respectively, of
SVIND serotype under T7 promoter in pBluescript SK(1)
ector were kindly provided by Dr. John K. Rose, Yale
niversity (Lawson et al., 1995). The wild-type NNJ as well
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226 DAS ET AL.s all the NNJ mutants made in SP6 transcription vector
GEM4 were subcloned into pBluescript SK(1) vector
nder the control of T7 promoter for using in in vivo
eplication experiment.
P6 transcription and in vitro translation
Plasmid DNAs were linearized with HindIII and puri-
ied by phenol:chloroform extraction and ethanol precip-
tation before in vitro transcription. SP6 transcription was
arried out in a 40-ml reaction containing 40 mM Tris–
Cl (pH 7.9), 6 mM MgCl2, 2 mM spermidine, 10 mM
aCl, 10 mM DTT, 40 units RNasin, unlabeled rNTPs (500
M each of ATP and GTP, 100 mM each of CTP and UTP
n case of leader RNA while 500 mM each of ATP, CTP,
nd UTP, 100 mmM GTP, and 500 mM m7GpppG in case
f N mRNA), 1 mg of linearized DNA template and 20
nits of SP6 RNA polymerase. For labeling RNA, 5 mCi of
-32P UTP (for mRNA synthesis) or 5 mCi each of a-32P
TP and CTP (for leader RNA synthesis) was included in
he reaction. Reactions were incubated at 40°C for 1 h.
he RNA products were then extracted with phenol:
hloroform and twice ethanol precipitated. The incorpo-
ation of labeled NTP was determined by binding to
hatman DE-81 filter paper and analyzed by electro-
horesis on polyacrylamide gel containing 8 M urea.
The in vitro translation of mRNAs was performed using
2 ml rabbit reticulocyte lysate (Promega), 15 units RNa-
in (Boehringer Mannheim), 7.5 mCi of [35S]-methionine
800 Ci/mmole), and 0.2–0.3 mg of mRNA in a 15-ml
eaction mixture. Incubation was carried out for 90 min at
0°C. The translation efficiencies of SP6 mRNAs were
0.4 mg of protein per mg of N mRNAs of either serotype.
n vitro encapsidation of leader RNA
The in vitro encapsidation of VSV leader RNA was
arried out in a reaction volume of 30 ml where ;0.1 mg
f 32P-labeled leader RNA (;100,000 cpm) was incu-
ated with appropriate mRNAs (0.4–0. 5 mg) at 30°C for
0 min in the presence of 21 ml of rabbit reticulocyte
ysate. RNaseA was then added to the reaction at a final
oncentration of 25 mg/ml and further incubated at 37°C
or 30 min. After RNaseA digestion, the reaction volume
as increased to 200 ml with TE. RNaseA was inacti-
ated by adding 1 mg of tRNA, 0.5% SDS, and proteinase
at a final concentration of 200 mg/ml. Samples were
hen extracted with phenol:chloroform and precipitated
ith ethanol. The protected RNA was analyzed by elec-
rophoresis on a 10% polyacrylamide gel containing 8 M
rea.
escue of infectious virus
BHK-21 cells in 60-mm plates grown in DMEM plus 7%
BS to ;70% confluency were infected with vTF7–3 at an
.o.i. of 10. After 30 min, plasmids encoding the VSVntigenomic RNA and the N, P, and L proteins were Dransfected into the cells using lipofectamine (Gibco)
ccording to the manufacturer’s protocol. The coding
egions for N, P, and L proteins were each expressed in
Bluescript SK(1) from the T7 promoter. The amounts of
lasmids used in the transfection were 5 mg of pVSV-
LIND(1), 3 mg of pBS-N (either serotype and mutants), 2
g of pBS-PIND, and 1 mg of pBS-LIND. After 24 h post-
ransfection in OPTI MEM, the transfection reagent was
eplaced with fresh DMEM containing 7% FBS and fur-
her incubated for 24 h at 37°C. Cells were then scraped
rom the dish and subjected to freeze-thaw cycles (270
nd 37°C) to release cell-associated virus. Cell debris
ere removed by centrifugation at 1500 g for 10 min. The
ntire lysate (;4 ml) was passed through a filter (0.2-mm
ore size, Millipore) to remove vaccinia virus. The recom-
inant VSV was pelleted by centrifuging the lysate at
00,000 g for 1 h. The pellet was suspended in DMEM
ithout FBS and used for infection of fresh BHK cells in
0-mm plate in the presence of 1-b-D-arabinofuranosyl-
ytosine (araC, 25 mg/ml). The plates were incubated at
7°C for 16–24 h until the cytopathic effect (CPE) was
bserved. The CPE was visualized by crystal violet stain-
ng. The production of virion particles in the medium was
etermined by plaque assay in the presence of araC.
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